BXP154B
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BXP154B, covering 2025-03-18 to 2025-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B [Phase 2]